GlassScriptPhysician profile
Shawn W Storm
NPI 1568653475
$4,089.83
in general payments reported to CMS, 2019-2025
23 companies · $181 in 2025
The $181 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $519 · 2020: $718 · 2021: $1,371 · 2022: $631 · 2023: $435 · 2024: $235 · 2025: $181.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $851.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $850.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $1,764.65 | 2020-2023 | Taperloc |
| Stryker Corporation | $403.22 | 2021-2023 | Blueprint Patient Specific Instrumentation, Gamma, Axsos |
| Depuy Synthes Sales INC. | $337.34 | 2019-2025 | Speed, Na, Va-Lcp |
| Pacira Therapeutics, INC. | $306.76 | 2019-2021 | |
| Bioventus LLC | $301.87 | 2019-2024 | Exogen Ultrasound Bone Healing System |
| Medical Device Business Services, INC. | $292.81 | 2019-2022 | |
| Nuvasive Specialized Orthopedics, INC. | $126.55 | 2022 | |
| Smith+Nephew, INC. | $119.99 | 2023-2025 | Grafix Pl, Stravix Pl, Stravix Mesh |
| Illuminoss Medical, INC. | $80.47 | 2023 | Photodynamic Bone Stabilization Procedure Pack |
| Endo Pharmaceuticals INC. | $72.86 | 2019-2022 | |
| Innovation Technologies INC | $35.91 | 2022 | |
| Lilly USA, LLC | $34.70 | 2020-2024 | Jardiance, Zepbound |
| Novo Nordisk INC | $30.53 | 2021-2023 | Wegovy |
| Janssen Pharmaceuticals, INC | $30.27 | 2021 | |
| Novartis Pharmaceuticals Corporation | $22.95 | 2019 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Davol INC. | $22.04 | 2023 | |
| Merck Sharp & Dohme LLC | $21.43 | 2021 | |
| Amgen INC. | $20.70 | 2025 | Prolia, Evenity |
| Pfizer INC. | $15.36 | 2020 | |
| Daiichi Sankyo INC. | $13.27 | 2021 | |
| Heraeus Medical, LLC. | $12.98 | 2019 | |
| Amarin Pharma, INC. | $11.67 | 2021 | |
| Horizon Therapeutics Plc | $11.50 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shawn Storm listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.